Literature DB >> 22428660

Assessment of concordance of symptom reflux association tests in ambulatory pH monitoring.

V M Kushnir1, A Sathyamurthy, J Drapekin, S Gaddam, G S Sayuk, C P Gyawali.   

Abstract

BACKGROUND: Both simple proportions and statistical tests are utilised for symptom-reflux association. We systematically compared three such tests in a clinical setting. AIM: To compare the three commonly used symptom reflux association tests in a large cohort of patients undergoing ambulatory pH monitoring for the evaluation of oesophageal symptoms.
METHODS: Ambulatory pH data from 772 symptomatic subjects (49.1 ± 0.5 years; 479 F) tested off therapy were assessed for acid exposure time (AET, elevated when pH <4 for ≥4%), symptom index (SI, ≥50% when positive), and symptom association probability (SAP) and Ghillebert probability estimate (GPE, P < 0.05 when positive). Test concordance and discordance were individually assessed; discordance between statistical tests was minor if one had P < 0.1 while the other was positive. Logistic regression determined independent predictors of test discordance.
RESULTS: The SAP, GPE and SI were positive in 42.7%, 39.3% and 33.9% respectively. GPE performed extremely well compared to SAP (sensitivity 0.95, specificity 0.91), with major discordance in only 2.8%. Positive concordance was significantly higher when AET was abnormal. GPE underestimated symptom association compared to SAP, whereas SAP was subject to symptom over-counting in 33.3% of discordant cases. GPE-SAP discordance was associated with higher AET (7.5% vs. 5.1%) and more symptoms (19.3 vs. 10.7, P > 0.001 for each comparison with concordant tests); both remained significant on logistic regression analysis (P ≤ 0.003). SI was discordant with SAP when symptoms were extremely frequent (median 19, IQR 10-32) or limited (median 1, IQR 1-2), and concordant when median 6 symptoms (IQR 3-12) were recorded.
CONCLUSIONS: The GPE can be used interchangeably with SAP in symptom reflux association. SI has uncertain value with very high and very low symptom counts.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22428660      PMCID: PMC3959626          DOI: 10.1111/j.1365-2036.2012.05066.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  19 in total

1.  Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication.

Authors:  G M Campos; J H Peters; T R DeMeester; S Oberg; P F Crookes; S Tan; S R DeMeester; J A Hagen; C G Bremner
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

2.  Value of preoperative esophageal function studies before laparoscopic antireflux surgery.

Authors:  Walter W Chan; Laura R Haroian; C Prakash Gyawali
Journal:  Surg Endosc       Date:  2011-03-18       Impact factor: 4.584

3.  The effect of antisecretory therapy and study duration on ambulatory esophageal pH monitoring.

Authors:  Vladimir M Kushnir; Gregory S Sayuk; C Prakash Gyawali
Journal:  Dig Dis Sci       Date:  2010-11-03       Impact factor: 3.199

4.  The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring.

Authors:  G J Wiener; J E Richter; J B Copper; W C Wu; D O Castell
Journal:  Am J Gastroenterol       Date:  1988-04       Impact factor: 10.864

5.  The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data.

Authors:  B L Weusten; J M Roelofs; L M Akkermans; G P Van Berge-Henegouwen; A J Smout
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

6.  The physiology and philosophy of cause and effect.

Authors:  W C Orr
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

7.  Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole.

Authors:  S A Taghavi; M Ghasedi; M Saberi-Firoozi; M Alizadeh-Naeeni; K Bagheri-Lankarani; M J Kaviani; L Hamidpour
Journal:  Gut       Date:  2005-04-21       Impact factor: 23.059

8.  Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease.

Authors:  Chandra Prakash; Ray E Clouse
Journal:  Clin Gastroenterol Hepatol       Date:  2005-04       Impact factor: 11.382

9.  Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease.

Authors:  James C Slaughter; Marion Goutte; Jennifer A Rymer; Amanke C Oranu; Jonathan A Schneider; C Gaelyn Garrett; David Hagaman; Michael F Vaezi
Journal:  Clin Gastroenterol Hepatol       Date:  2011-07-23       Impact factor: 11.382

10.  Ambulatory 24 hour intraoesophageal pH and pressure recordings v provocation tests in the diagnosis of chest pain of oesophageal origin.

Authors:  G Ghillebert; J Janssens; G Vantrappen; F Nevens; J Piessens
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

View more
  18 in total

1.  Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease.

Authors:  Amit Patel; Gregory S Sayuk; C Prakash Gyawali
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-23       Impact factor: 11.382

2.  GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation.

Authors:  A Patel; G S Sayuk; V M Kushnir; W W Chan; C P Gyawali
Journal:  Neurogastroenterol Motil       Date:  2015-12-20       Impact factor: 3.598

Review 3.  Optimizing the Use of Medications and Other Therapies in Infant Gastroesophageal Reflux.

Authors:  Steven L Ciciora; Frederick W Woodley
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

4.  Genetic risk factors for perception of symptoms in GERD: an observational cohort study.

Authors:  A Patel; S Hasak; B D Nix; G S Sayuk; R D Newberry; C P Gyawali
Journal:  Aliment Pharmacol Ther       Date:  2017-11-17       Impact factor: 8.171

Review 5.  Expert consensus document: Advances in the physiological assessment and diagnosis of GERD.

Authors:  Edoardo Savarino; Albert J Bredenoord; Mark Fox; John E Pandolfino; Sabine Roman; C Prakash Gyawali
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-09-27       Impact factor: 46.802

6.  Symptom index P-value and symptom sensitivity index P-value to determine symptom association between apnea and reflux in premature infants at term.

Authors:  D R Glen; P Murakami; J S Nunez
Journal:  Dis Esophagus       Date:  2012-11-16       Impact factor: 3.429

7.  Inconsistency in the Diagnosis of Functional Heartburn: Usefulness of Prolonged Wireless pH Monitoring in Patients With Proton Pump Inhibitor Refractory Gastroesophageal Reflux Disease.

Authors:  Roberto Penagini; Rami Sweis; Aurelio Mauro; Gerson Domingues; Andres Vales; Daniel Sifrim
Journal:  J Neurogastroenterol Motil       Date:  2015-03-30       Impact factor: 4.924

8.  Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring.

Authors:  A Patel; G S Sayuk; C P Gyawali
Journal:  Neurogastroenterol Motil       Date:  2016-04-08       Impact factor: 3.598

9.  Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors.

Authors:  Valentin Becker; Stefan Grotz; Christoph Schlag; Simon Nennstiel; Analena Beitz; Bernhard Haller; Roland M Schmid; Alexander Meining; Monther Bajbouj
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

10.  Gastroesophageal reflux after per-oral endoscopic myotomy is frequently asymptomatic, but leads to more severe esophagitis: A case-control study.

Authors:  Arun Karyampudi; Zaheer Nabi; Mohan Ramchandani; Santosh Darisetty; Rajesh Goud; Radhika Chavan; Rakesh Kalapala; Guduru Venkat Rao; Duvvur Nageshwar Reddy
Journal:  United European Gastroenterol J       Date:  2021-02-18       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.